Enter your terms above and click the 'Search' button.

Showing articles 0 to 4 of 4 Filter Applied: biologic markers (Click to remove) Inhibition of CD40L with Frexalimab in Multiple Sclerosis NEJM 390:589-600, 662, Vermersch,P.,et al, 2024 Lecanemab in Early Alzheimers Disease NEJM 388:9-21,80, van Dyck,A.H.,et al, 2023 Natalizumab-Associated PML Neurol 88:1197-1205, Schwab, N.,et al, 2017 Statin-Associated Autoimmune Myopathy NEJM 374:664-669, Mammen, A.L., 2016 Showing articles 0 to 4 of 4